The country, which has been plagued by the corona virus epidemic for the past year, received good news in the first three days of the new year. On Sunday, India’s Drug Controller General (DCGI) approved India’s Serum Institute of Covishield and India Biotech’s Covaxin for emergency use. Earlier, both were approved by the expert panel. However, in the midst of vaccine relief, ICMR DG Dr. Balaram Varghese made a big statement. Bharatgaba said he also did not know how long the vaccine would be effective.
After the approval of SII and India Biotech Vaccine, Dr. Balaram Varghese said, “We do not know how many people need to be vaccinated to eradicate the virus. What we do know is that by following proper behavior we have been able to control the epidemic in the country. He also gave important information about the mask. Bharagava said, “I think the mask will be the last one, which will go away and it may be that it will never go away.”
‘Soon Corona will be able to separate new strains’
The recent release of a new strain of coronavirus in Britain caused a stir around the world. Many new strains have been reported in India. ICMR’s Dr Balram Varbhava also expressed concern. “The new virus form which is now more than 60% contagious and causing destructive causes in the UK,” he said. There are 29 new strain patients in India, so we should be careful. We were soon able to isolate the new virus. He added that NIV scientists have successfully isolated strains of the new virus and that it will be tested by various vaccines. We hope that India Biotech will benefit more than other vaccines in this strain.
NIV scientists have successfully isolated strains of the new virus and it will be tested against various vaccines. We hope that the potential India biotech vaccine will benefit from other vaccines in this new strain because it is a complete virus: Dr. Balram Varghese, DG ICMR https://t.co/i3DxNoJnD3
– ANI (@ANI) January 3, 2021
Two coronary vaccines are approved on an emergency basis
On Sunday, Oxford coroner vaccine ‘Kovishield’ and India Biotech’s indigenous vaccine “Kovacin” manufactured by India Serum Institute of India were approved for emergency use in the country. Vaccination will also start in India soon. This approval has been given by DCGI on the recommendation of the Subject Expert Committee in CDSCO’s COVID-19. This has paved the way for the release of at least two vaccines in India in the coming days. The World Health Organization (WHO) has also welcomed the approval of vaccines. The agency said it would help intensify the fight against epidemics in the region.